Hikma Pharmaceuticals (HIK) Stock Chart & Stock Price History GBX 1,794.30 -20.70 (-1.14%) As of 07:02 AM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesSustainabilityBuy This Stock Hikma Pharmaceuticals Stock Price Performance The Hikma Pharmaceuticals (HIK) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 9.97%, with a year-to-date return of -10.41%. In the past month, the stock has decreased 9.20%, reflecting recent market activity. As of the latest close, Hikma Pharmaceuticals traded at GBX 1,815 with a market cap of £5.03 billion and volume of 549,662 shares. Five years ago, the stock traded at GBX 2,356, representing a 23.84% decrease over that period. At the time, it had a market cap of £5.43 billion and a volume of 571,398 shares. Receive HIK Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Hikma Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-2.27%1 Month Performance-9.20%3 Month Performance-15.76%Year-To-Date Performance-10.41%1 Year Performance-9.97%5 Year Performance-23.84% HIK Stock Chart for Friday, August, 29, 2025 HIK Chart by TradingView Hikma Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/28/2025GBX 1,843GBX 1,815-1.52%GBX 1,848GBX 1,806549,662 shs£5.03 billion08/27/2025GBX 1,820GBX 1,843+1.26%GBX 1,849GBX 1,822.58469,626 shs£5.11 billion08/26/2025GBX 1,836GBX 1,820-0.87%GBX 1,840GBX 1,818959,363 shs£5.05 billion08/25/2025GBX 1,836GBX 1,836GBX 1,854.34GBX 1,814250,613 shs£5.09 billion08/22/2025GBX 1,821GBX 1,836+0.82%GBX 1,854.34GBX 1,814250,613 shs£5.09 billion08/21/2025GBX 1,811GBX 1,821+0.55%GBX 1,821GBX 1,798.44317,505 shs£5.05 billion08/20/2025GBX 1,809.13GBX 1,811+0.10%GBX 1,816GBX 1,793279,569 shs£5.02 billion08/19/2025GBX 1,801.59GBX 1,809.13+0.42%GBX 1,826GBX 1,782382,185 shs£5.02 billion08/18/2025GBX 1,793.30GBX 1,801.59+0.46%GBX 1,814GBX 1,790893,383 shs£5.00 billion08/15/2025GBX 1,791.88GBX 1,793.30+0.08%GBX 1,800GBX 1,785446,468 shs£4.97 billion Get the Latest News and Ratings for HIK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hikma Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 08/14/2025GBX 1,804.79GBX 1,791.88-0.72%GBX 1,810GBX 1,777783,896 shs£4.97 billion08/13/2025GBX 1,777.29GBX 1,804.79+1.55%GBX 1,817GBX 1,787849,039 shs£5.00 billion08/12/2025GBX 1,776.15GBX 1,777.29+0.06%GBX 1,799GBX 1,761690,601 shs£4.93 billion08/11/2025GBX 1,729.97GBX 1,776.15+2.67%GBX 1,792GBX 1,738667,189 shs£4.93 billion08/08/2025GBX 1,751.13GBX 1,729.97-1.21%GBX 1,770GBX 1,706663,795 shs£4.80 billion08/07/2025GBX 1,884GBX 1,751.13-7.05%GBX 1,804GBX 1,6901.91 million shs£4.86 billion08/06/2025GBX 1,916GBX 1,884-1.67%GBX 1,929GBX 1,884473,161 shs£5.22 billion08/05/2025GBX 1,931.90GBX 1,916-0.82%GBX 1,946.18GBX 1,916496,837 shs£5.31 billion08/04/2025GBX 1,934.03GBX 1,931.90-0.11%GBX 1,950GBX 1,928.541.35 million shs£5.36 billion08/01/2025GBX 1,964GBX 1,934.03-1.53%GBX 1,952GBX 1,925385,310 shs£5.36 billion07/31/2025GBX 1,995GBX 1,964-1.55%GBX 2,004GBX 1,9621.89 million shs£5.45 billion07/30/2025GBX 1,976GBX 1,995+0.96%GBX 1,999GBX 1,961.86243,840 shs£5.53 billion07/29/2025GBX 1,992GBX 1,976-0.80%GBX 2,002GBX 1,976308,519 shs£5.48 billion07/28/2025GBX 2,004GBX 1,992-0.60%GBX 2,024GBX 1,992242,153 shs£5.52 billion Related Companies HUTCHMED Stock Price Chart Indivior Stock Price Chart Allergy Therapeutics Stock Price Chart Alliance Pharma Stock Price Chart Animalcare Group Stock Price Chart Shield Therapeutics Stock Price Chart Venture Life Group Stock Price Chart ECO Animal Health Group Stock Price Chart Provexis Stock Price Chart Chill Brands Group Stock Price Chart Receive HIK Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Hikma Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (LON:HIK) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hikma Pharmaceuticals PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Hikma Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access